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Integrating an Automated Diabetes
Management System Into the Family
Management of ChildrenWith Type 1
Diabetes
Results from a 12-month randomized controlled technology trial
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KEVIN L. MCMAHON, BS9
OBJECTIVEdThe study objective was to evaluate how the use of a pervasive blood glucose
monitoring (BGM) technology relates to glycemic control, report of self-care behavior, and
emotional response to BGM of children with type 1 diabetes and their parents.
RESEARCH DESIGN AND METHODSdForty-eight children aged less than 12 years
(mean 8.8 years) with type 1 diabetes were randomly assigned to one of two study groups, a control
group (conventional care without technology) or an experimental group (conventional care with
technology), and followed for 12 months. Families in the experimental group were given the Au-
tomated Diabetes Management System (ADMS), which automatically collects blood glucose (BG)
values and sends to parent(s) a 21-dayBG trending report via e-mail eachnight.Measures of glycemic
control (HbA1c) were collected at baseline and at quarterly diabetes clinic visits; BGM effect and
diabetes self-care behavior measures were obtained at the baseline, 6-month, and 12-month visits.
RESULTSdChildren in the experimental group had signiﬁcantly (P = 0.01) lower HbA1c at 12
months (7.44 6 0.94, 20.35 from baseline) than controls (8.31 6 1.24, +0.15 from baseline).
Improvement in HbA1c was more profound in families using the ADMS more frequently. In
addition, in these families, parents showed a signiﬁcant improvement in BGM effect (P = 0.03)
and children became more meticulous in diabetes self-care (P = 0.04). Children in both exper-
imental and control groups experienced no change in their emotional response to BGM.
CONCLUSIONSdUsing the ADMS 1–3 times/week may help children with type 1 diabetes
improve glycemic control and gain diabetes self-management skills, as well as improve the BGM
effect of parents.
Diabetes Care 35:498–502, 2012
P ervasive computing, also called“ubiquitous computing,” is the no-tion that applications are no longer
restricted to desktop computers but rather
embedded into objects used in everyday life
and always available. Pervasive technologies
are therefore uniquely suited to support
children with type 1 diabetes and their fam-
ilies as they cope with the complex, daily
routines of diabetes care. For example, per-
vasive technologies that work together to
automatically record and display blood
glucose monitoring (BGM) data can be an
aid to parents by heightening awareness of
blood glucose (BG) trends and sustaining
engagement with their child’s diabetes
management. Prior research has established
the value of parental involvement in the
care of children with type 1 diabetes (1,2).
A technology that eases the burden of col-
lecting and reﬂecting on BGM data also
stands to improvediabetes self-management
in children, which has been correlated
with better glycemic control (3). However,
there is also potential for these types of
monitoring technologies to create a nega-
tive attitude toward BGM because of an in-
creased focus on BG values and possible
perception by the child of increased surveil-
lance. Negative BGM effect has been asso-
ciated with poor glycemic control (4).
Commercial devices designed to support
remote BGM are increasingly being pro-
duced; thus, it is important to understand
the potential impact of integrating this type
of technology into the family context of di-
abetes management. The goal of this re-
search was to understand how a particular
pervasive remote BG monitoring technol-
ogy inﬂuences glycemic control, diabetes
self-management, and attitudes toward
BGM. In this study, the Automated Diabe-
tes Management System (ADMS) by Diabe-
tech, LP (Dallas, TX; http://healthimo.com/
glucomon) was provided to children with
established type 1 diabetes and their pa-
rents to measure the effect of automated
BGM data collection and trend reporting
on self-care behaviors, glucose control,
and attitudes toward BGM compared with
conventional management. Prior research
has shown the ADMS to be an effective
means of self-monitoring BG, allowing early




Study participants were children with
type 1 diabetes and their parents who
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were followed at an outpatient diabetes
clinic associated with a tertiary care child-
ren’s hospital in the SouthwesternU.S.. All
subjects had type 1 diabetes for at least 1
year. This criterion was intended to mini-
mize the effect of the honeymoon period
on HbA1c levels. To minimize the impact
of oppositional behaviors on glycemic
control, only children with no diagnosed
major psychoaffective disorders were eli-
gible to participate.
Patient records were reviewed for the
following eligibility criteria: duration of
type 1 diabetes.1 year and age,12 years
at the time of enrollment. Exclusion criteria
were prior involvement with foster care,
juvenile justice system, or children’s pro-
tective services, or subject expected to live
in the same home environment for ,1
year; patients with known psychiatric and
behavioral disorders other than attention
deﬁcit disorder (as deﬁned by a medical
diagnosis recorded in the patient chart by
the patient’s physician); and HbA1c.12%
at enrollment. Written informed consent
was obtained from all families before entry.
Procedure
In total, there were 120 children followed
in the practice who met the inclusion
criteria, 12 of whomwere excluded on the
basis of the deﬁned criteria. Patients were
recruited when they came into the clinic
for routine visits or by phone until the
maximum number of participants was
met with a total of 64 families invited to
participate in the study. Subjects were
randomly assigned to one of two study
groups: the control group (conventional
care without ADMS) or the experimental
group (conventional care with ADMS).
During the 12-month study period, all
subjects from both study groups were
seen ﬁve times beginning with an initial
baseline screening appointment, during
which various demographic, glycemic
control, and psychosocial data were col-
lected. Families were seen quarterly for
routine diabetes clinic visits, during which
relevant information was gathered. Nei-
ther group was asked to monitor BG any
more or less frequently than other pa-
tients with type 1 diabetes in the practice.
Two registered BG meters and test strips
(OneTouchUltra byLifeScan, Inc.,Milpitas,
CA) were given to families in both the
control and experimental groups. Subjects
agreed to use only these devices for BGM
for the duration of the study.
Both groups were seen by the same
health care team and provided the same
level of care without additional contact.
All participants were told that their BGM
information was for their use only and
would not be monitored by the diabetes
team from a distance. Families attending
this clinic are routinely asked to forward
BGM information between clinical visits if
there is concern about glucose control or
if need for changes in diabetes manage-
ment arises. This practice did not change
within the experimental or control group.
The health care team did not explicitly
encourage use of the ADMS and treated
patients in the experimental group with-
out bias.
Participants enrolled in the experi-
mental group were provided the ADMS
equipment and service free of charge for
the study duration. As an incentive,
subjects in the control group were of-
fered use of the ADMS for 6 months after
the completion of their participation in
the study. There were no other incentives
for participation provided to either
group.
Intervention
The ADMS is composed of the GlucoMON
and GlucoDYNAMIX (Diabetech, LP),
which are wireless technologies that
work together to provide automated BGM
data retrieval, analysis, and reporting. The
experimental group subjects had access to
two features within the GlucoDYNAMIX,
including 1) “real-time alerts,” notiﬁcation
by text message to cell phones or e-mail of
the last BG result immediately after the
dockingof theglucometer to theGlucoMON
device, and 2) “trend analysis reports,” a
daily e-mail to parents including the system-
generated 21-day BG log attached as a PDF
document (Fig. 1). The report is color
coded and arranged by date (on the
y-axis) and time (on the x-axis). Elevated
BG values are shown in red, and low BG
results are shown in yellow. When two
readings occur within the same hour,
a blue color is displayed along with the
information. Readings in white boxes are
“within range.”
Participants were free to use data from
the ADMS as they saw ﬁt for diabetes
management purposes. They were advised
to dock their meter(s) daily or more often if
they wanted, but at a minimum, they
should dock weekly. One family had no
Internet access, so their trend analysis re-
ports were mailed to their home each week.
Reports were not automatically sent to the
diabetes care team, and no speciﬁc health
care provider–initiated action was triggered
by ADMS reports. It was left to the family to
decide what (if any) action should be taken
on the basis of knowledge of self-care gained
through glucose pattern management skills
training before enrollment.
Measurements
The effectiveness of the intervention was
measured in three ways 1) glycemic con-
trol, 2) patient and parent effect around
BGM, and 3) parent report of child’s self-
management behavior.
Measure of glycemic control. HbA1c
was collected using an aqueous ﬁnger
stick 3-mL blood sample collection kit
including a prepaid mailer to the study’s
centralized laboratory (DTI Laboratories,
Inc., Thomasville, GA). TheHbA1cmethod
used for this study used a multimethod
sample screening via high-performance liq-
uid chromatography-ion exchange for de-
tecting possible interference followed by
high-performance liquid chromatography-
bioassay analysis to determine the percent
HbA1c. HbA1c was collected using this
method at enrollment and 3-month inter-
vals for every participant for the duration
of the study.
Measure of patient and parent effect
around BGM. Both parent and child
completed the Blood Glucose Monitoring
Communication (BGMC) questionnaire
at the baseline, 6-month, and 12-month
visits to assess the emotional response to
BGM when the ADMS is added to routine
diabetes care. The BGMC questionnaire
is a validated (4) eight-question survey that
gauges emotional response to BGM. Chil-
dren were asked to reﬂect on how it felt
when their BG was out of range. Likewise,
questions aimed at parents asked them to
report the level of concern that they had for
their child in such situations. The total
Figure 1dA 21-day trend analysis report,
GlucoMON device and real-time alert. BG,
blood glucose.
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score of the survey was used to evaluate
BGM effect where a minimum score of 8
reﬂected a more positive emotional re-
sponse and higher scores reﬂected up
to a maximum of 24 points, which are
indicative of negative feelings toward
BGM.
Measure of diabetes self-management.
All participants completed a Diabetes
Self-Management Proﬁle (DSMP) at the
baseline, 6-month, and 12-month visits.
The DSMP is a semistructured interview
that is a validatedmeasure of diabetes self-
management (3). Parents were inter-
viewed in this study, but prior work has
shown little difference between child and
parent responses (3). The questions are
grouped into subscales related to each
area of self-care andhave a range of possible
points as follows: exercise (0–12), man-
agement of hypoglycemia (0–11), diet
(0–17), BG checking (0–33), and insulin
administration and adjustment (0–16).
Higher scores on the DSMP indicate
more rigorous diabetes self-management
along the ﬁve subscales. High DSMP
scores have been associated with im-
proved glycemic control (3).
Statistical analysis
Statistical analysis of the data was per-
formed using the Statistical Package for
the Social Sciences (PASW Statistics 18
for Windows; SPSS Inc., Chicago, IL).
The analyses included unpaired t tests,
ANOVA, two-way ANOVA, Pearson bi-
variate correlations, x2 and Fisher exact
tests. P values,0.05 were considered sig-
niﬁcant. Values are reported as mean 6
SD unless otherwise noted. Change in
HbA1c, BGMC, and DSMP were analyzed
according to study group (experimental
vs. control) and ADMS use. To evaluate
the impact of prestudy glycemic control,
these groups were further segmented dur-
ing analysis by baseline HbA1c: subjects
who began the study with 1) HbA1c
.8% and 2) HbA1c #8%.
RESULTS
Participant characteristics
Fifty-four eligible families (84% of the 64
families invited) volunteered to partici-
pate and were randomly assigned to one
of two study groups: 27 families in the
control group (conventional care without
ADMS) and 27 families in the experimen-
tal group (conventional care with ADMS).
Three families from each group dropped
out of the study, leaving a total of 48
families: 24 in the experimental group
and 24 in the control arm. Five of the 6
families dropped out because of relo-
cation. One family exited the experi-
mental group after 3 months because
the patient’s mother found the color-
coded log generated by the ADMS to
be confusing. Retrospective analysis re-
vealed no statistically signiﬁcant differ-
ence between the experimental and
control groups in the demographic
and clinical characteristics presented
in Table 1.
ADMS use
ADMSuse rateswere deﬁned using system-
recorded docking events collected for
each subject in the experimental group
throughout the study. A docking event is
created when a glucometer is connected
to the GlucoMON, and all BG readings
in the memory are downloaded to the
system. Each date and time-stamped event
is associated with an individual subject
through the GlucoMON identiﬁcation
number.
Although experimental group partic-
ipants were encouraged at enrollment to
dock weekly, no encouragement to use
the ADMS was given during the study.
Three distinct groups of use emerged:
1) docked,1 time each week (0.56 0.2
events/week, n = 13); 2) docked 1–2 times
each week (1.46 0.3 events/week, n = 8);
and 3) docked.2 times each week (3.16
0.2, n = 3). Multiple ANOVA tests showed
no difference in glycemic control, BGMC,
or DSMP between groups 2 and 3, so they
were combined into a single group deﬁned
as docking 1–3 times/week. Therefore, in
addition to comparisons between the
control group and the experimental
group as a whole, the ADMS use groups
A (docking ,1 time/week), B (docking
1–3 times/week, and C (control group)
are used to categorize the study out-
comes. There was a steady use of the de-
vice in group A throughout the study.
Participants in group B used the device
more sporadically and never achieved
the same level of use on a weekly basis
as those in group A. In group B, there was
one family who docked only one time and
two families who stopped docking com-
pletely after 8 months. Other ﬁndings
around docking patterns are not reported
in this article because of space con-








Patient age, years (mean 6 SD) 8.7 6 2.2 8.3 6 2.7
Diabetes duration, months (mean 6 SD) 47.2 6 27.7 43.8 6 24.4
Baseline HbA1c (mean 6 SD) 7.9 6 0.81 8.1 6 1.32
Sex: male 13 (54.2) 15 (62.5)
Family structure
Two parents/guardians 21 (87.5) 17 (70.8)
Single parent/guardian 3 (12.5) 7 (29.2)
Ethnicity
White, non-Hispanic 15 (62.5) 14 (58.3)
Hispanic 8 (33.3) 10 (41.7)
Native American 1 (4.2) 0
Language
English 22 (91.7) 23 (96.8)
Spanish 2 (8.3) 1 (4.2)
Insurance status
Insured 19 (79.2) 15 (62.5)
Medicaid 5 (20.8) 9 (37.5)
Education levela
#12 years 6 (25.0) 7 (30.4)
Partial college 8 (33.3) 8 (34.8)
Bachelor of Arts 7 (29.2) 6 (26.1)
Master’s 3 (12.5) 2 (8.8)
Data are expressed as n (percentages) unless stated otherwise. aEducation level is for parent/guardian and
represents highest level attained of the two parents or guardians (no information for one control group
participant).
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Of note, there were no statistically
signiﬁcant differences in baseline demo-
graphic or clinical characteristics among
ADMS use groups A, B, and C, including
age, ethnicity, educational level, insur-
ance status, language, duration of diabe-
tes, baseline HbA1c values, and baseline
parental BGMC, child BGMC, or DSMP
scores. In addition, there were no statisti-
cally signiﬁcant differences in the demo-
graphic characteristics between experimental
groups A and B. Both groups had a similar
number of parents with a college educa-
tion or more (5) and similar family struc-
ture; group A had two one-parent families
versus one found in group B. All families
had computer access except one family in
group B, which may have contributed to
the initial low rate of docking (1–3 times/
week) and complete decrease in use during
the last 4 months of the study.
Glycemic control
An independent-samples t test was con-
ducted to compare glycemic control be-
tween the experimental group and the
control group. The results showed that
the mean 12-month HbA1c value of the
experimental group (7.44 6 0.94) was
signiﬁcantly lower than of the control
group (8.316 1.24), conﬁrming that gly-
cemic control improved in the experi-
mental group when compared with the
control group (P = 0.01).
To examine the impact of prestudy
glycemic control, the experimental and
control groups were divided according to
baseline HbA1c: Exp,8 or Ctrl,8 indi-
cate groups that met the American Dia-
betes Association’s target values, and
Exp$8 or Ctrl$8 indicate those who
were over target (1). A two-way ANOVA
found that participants in the Exp$8
group had a lower mean HbA1c at 12
months (7.68 6 1.04) compared with
counterparts in the Ctrl$8 group
(9.55 6 1.20), revealing signiﬁcantly im-
proved glycemic control in the experimen-
tal group (P = 0.04). There was no
signiﬁcant difference in HbA1c at 12
months in the Exp,8 group (7.29 6
0.87) and the Ctrl,8 group (7.696 0.72).
To evaluate the relationship between
docking event frequency and changes in
HbA1c, an ANOVAwas conducted to con-
trast the change in glycemic control expe-
rienced by the three ADMS use groups. As
shown in Table 2, there was a signiﬁcant
relationship between docking frequency
and glycemic control (P = 0.02). ANOVA
tests revealed that subjects using the
ADMS 1–3 times/week had signiﬁcantly
lower HbA1c at 12 months when com-
pared with the control group (P = 0.01).
The change in HbA1c from baseline to 12
months for subjects using the ADMS 1–3
times/week was also signiﬁcantly greater
than in the control group (P = 0.04). The
change in HbA1c for subjects docking,1
time/week did not differ signiﬁcantly
from the control group (P = 0.33) or the
group docking 1–3 times/week (P = 0.35).
BGM effect
An independent-samples t test was con-
ducted to determine whether there were
differences in BGMC scores of the exper-
imental group compared with the control
group. The results show that there were
no signiﬁcant differences in BGMC scores
of children. The t test examining the
change in parental BGMC scores showed
the experimental group had a trend to-
ward improvement in BGMC when com-
pared with parents in the control group
(20.6526 2.72 vs. 1.046 3.41; P = 0.07).
In addition, the experimental group had a
signiﬁcantly greater number of subjects
with a stable or improved parental BGMC
scores from baseline to 12 months com-
pared with the control group (78 vs.
46%; P = 0.02). ANOVA showed that pre-
study glycemic control had no relationship
to the BGMC scores of parents or children.
An ANOVA was conducted to inves-
tigate the relationship between docking
frequency and change in BGMC scores. As
shown in Table 2, there were no signiﬁ-
cant differences in the BGMC scores of
children; however, the change in BGMC
scores of parents between baseline and 12
months was signiﬁcantly different among
the three groups (P = 0.04). Post hoc,
pairwise comparisons show that parents
in the group using the ADMS 1–3 times/
week had signiﬁcantly improved BGM ef-
fect than the control group (P = 0.03).
There was no signiﬁcant difference in
the BGM effect between those using the
ADMS ,1 time/week and the control
group (P = 0.83).
Diabetes self-management
An independent-samples t test was con-
ducted to determine whether there were
differences in DSMP scores of the experi-
mental group compared with the control
group. There were no signiﬁcant differen-
ces found between experimental and con-
trol at any phase of the study, at baseline,
6months, or 12months. ANOVA showed
that prestudy glycemic control, as mea-
sured by baseline HbA1c, also was not re-
lated to DSMP scores.
To investigate possible connections
between use rates of the ADMS and the
change in diabetes self-care, ANOVA tests
were conducted evaluating the relation-
ship of docking frequency with DSMP
scores. There was a signiﬁcant difference







(n = 24) P valuea
HbA1c
Baseline 8.0 6 0.8 7.8 6 1.0 8.1 6 1.3 0.02 (0.35, 0.33, 0.01)
6 months 8.3 6 0.9 7.3 6 0.6 8.2 6 1.5
12 months 7.8 6 1.1 7.1 6 0.6 8.3 6 1.3
BGMC parent
Baseline 13.6 6 4.0 13.1 6 3.6 13.5 6 3.2 0.04 (0.19, 0.83, 0.03)
6 months 14.1 6 4.5 11.5 6 2.1 14.0 6 3.8
12 months 14.3 6 4.0 11.3 6 2.3 14.5 6 4.1
BGMC child
Baseline 12.2 6 3.7 12.4 6 2.2 12.7 6 3.5 0.68 (not applicable)
6 months 12.4 6 3.0 11.2 6 2.1 13.0 6 3.5
12 months 12.4 6 3.1 12.5 6 2.7 13.4 6 3.4
DSMP
Baseline 62.0 6 7.3 63.8 6 5.7 59.5 6 9.9 0.03 (0.06, 0.99, 0.04)
6 months 61.6 6 8.1 67.1 6 7.8 64.2 6 10.2
12 months 61.3 6 9.8 71.2 6 8.3 61.8 6 10.7
Data are reported as mean 6 SD unless otherwise noted. aP values from ANOVA model for HbA1c at 12
months, change in BGMC scores for parent and children from baseline to 12 months, and DSMP score at 12
months. The ﬁrst P value for each variable represents the three-group comparison, followed by post hoc
pairwise comparisons (A vs. B, A vs. C, B vs. C) using Tukey honestly signiﬁcant difference.
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in the 12-month DSMP scores of the three
groups shown in Table 2 (P = 0.03). Pair-
wise comparisons, also shown in Table 2,
indicate that subjects using the ADMS 1–3
times/week had signiﬁcantly higher DSMP
scores than subjects in the control group
(P = 0.04) and a trend for higher scores
than those who docked with the ADMS
less than once/week (P = 0.06).
The scores for each of the ﬁve subscales
within the DSMP were also analyzed. No
differences were found between ADMS
docking groups at baseline; however, by
the 12-month interview there were signif-
icantly different scores for the BG checking
subsection (P = 0.03). Pairwise compari-
sons indicated that those using the ADMS
1–3 times/week had higher 12-month
scores in the BGM subscale (26.8 6 4.35)
than the control group (21.966 5.53; P =
0.03) and the group using the ADMS ,1
time/week (21.926 4.44; P = 0.06).
CONCLUSIONSdTo be successful,
data capture technologies, such as the
ADMS, must reduce the burden of col-
lecting and analyzing the data to a point
where it does not interfere with ordinary
activities of daily living (7). Toward this
goal, our study was designed to under-
stand realistic use of the ADMS by simply
giving the device to families and studying
the ways in which they appropriated the
technology.We do not knowwhether any
relationship exists between BGM fre-
quency and ADMS use because the study
was conducted in a clinic setting; therefore,
these data were incomplete. However, our
ﬁndings do suggest that frequency of dock-
ing had a signiﬁcant relationship with the
measures examined. Speciﬁcally, docking
1–3 times/week (an average of 1.9 times/
week over the 12 months) was associated
with signiﬁcant improvements in the gly-
cemic control and self-care skills in chil-
dren, and had a positive effect on the
BGM effect of parents.
The signiﬁcant reduction in HbA1c
coupled with the improved and stable
BGMC scores of parents and children, re-
spectively, is a particularly important
ﬁnding from this research. The emotional
response to viewing the results of a BG
check on a glucometer has an established
relationship with glycemic control, that
is, lower scores on the BGMC, indicating
a more positive BGM effect, have been cor-
related with lower HbA1c values in prior
research (4). Therefore, an important con-
sideration for the design of technology for
children with type 1 diabetes is to, at the
very least, do no harm to the emotions of
the child or parents with interventions
aimed at BGM. Although the BGMC scores
of children were not signiﬁcantly changed
through the use of the ADMS, they did not
get any worse, and we assume that no
harm was done. This is an important ﬁnd-
ing given that this technology is designed
to increase the amount of reﬂection on BG
values through real time alerts and daily
trending reports; thus, it has the potential
to make bad feelings worse.
This study contributes to the larger
body of knowledge about how remote
data capture technologymay be beneﬁcial
to children and families coping with type
1 diabetes. Taken together, the results of
this study and others that have investi-
gated the use of pervasive technologies to
promote BG monitoring (6,8–10) reveal
the promise of such devices. The limita-
tions of this study include the relatively
small sample size of 48 families. To make
stronger claims about the beneﬁt of the
ADMS, the study would need to be repli-
cated with a larger set of participants. In
addition, approximately half of the fami-
lies in the experimental group used the
ADMS less than one time each week
throughout the study and some stopped
completely after several months of use,
revealing a need for further design work
aimed at encouraging the sustained use of
the technology. It is difﬁcult to believe
that the high level of engagement seen in
the group docking 1–3 times/week would
have beenmaintained if the parents or chil-
dren did not look at the alerts or trending
reports. A higher number of docking events
translates to more system-generated real-
time alerts and more complete 21-day
trending reports. Therefore, it may be that
improvements found in families docking
more frequently were related to an in-
creased reﬂection on BG data, but there
may have been any myriad factors contrib-
uting to this relationship. Future work
should examine the personal and family
contextual factors that present barriers to
the use of technologies that ease the burden
of collecting and reﬂecting on BG data.
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